As the Asia Pacific region is set to bear the brunt of the global burden of fragility fractures by mid-century, clear, measurable, national action plans must be devised and implemented at scale, according to the authors of a new review. Titled ‘Quality improvement initiatives in the care and prevention of fragility fractures in the Asia …
According to a new review, a significant proportion of the systematic approach to care and prevention of fragility fractures proposed in Osteoporosis New Zealand’s BoneCare 2020 was developed and implemented during 2012 to 2022. However, progression of existing initiatives, and the introduction of new initiatives are required to further address fracture prevention in the country. The …
New Zealand’s report card on fragility fractures: a review of BoneCare 2020 Read More »
Each year World Osteoporosis Day, which falls on October 20, offers an important reminder to all bone-related stakeholders – orthopaedic surgeons, geriatricians, physicians, paramedics, patients, policy makers, and the community alike – of our collective role in ensuring good bone health for all. Orthopaedic surgeons are pivotal to the early diagnosis and treatment of osteoporosis …
Appeal for orthopaedic surgeons to more proactively lead and champion bone health Read More »
During the pandemic year 2020, New Zealand’s Fracture Liaison Service (FLS) expanded and consolidated to deliver better, broader, secondary fracture prevention in order to minimise the burden of fragility fractures afflicting its ageing population, outlines a new article. The New Zealand Medical Journal article, Expansion and consolidation of fracture liaison service in New Zealand public …
New Zealand raises the bar on growth & refinement of FLS Read More »
Osteoporotic fractures are a major and growing public health problem worldwide due to the ageing population and associated morbidities that increase fracture risk.1,2,3 In Australia, fragility fractures affect one in four men, and two in five women aged 50 years and older.4 Yet, despite the widespread availability of effective medications5,6 that lower fracture risk and mortality7, …
Helping to stem the tide of fractures in the Asia Pacific – the world’s most populated and fastest ageing region The Asia Pacific Consortium on Osteoporosis (APCO) launched a Bone Health QI Tool Kit for healthcare professionals (HCPs) this week, to promote quality improvement (QI) of osteoporosis care. Designed to help stem our regional bone …
Japan is a super-ageing society. While its population boasts the world’s second-longest life expectancy, it does however, have a growing number of older people living with hip fractures.1 The estimated total number of new patients who presented to hospital with a hip fracture in Japan during 2012 was 175,7002 – a figure projected to increase …
Hip fracture multi-modal care breaking new ground in Japan Read More »
Fragility fractures are associated with high rates of disability, loss of independence, reduced quality of life for both patients and their carers, not to mention significant costs to healthcare systems.1 Despite the high associated morbidity and mortality, osteoporosis remains under-diagnosed and under-treated.2 Those who experience a fragility fracture are at high risk of re-fracture. Post-fracture …
Snapshot of the global landscape of PFC programs Read More »
Patients living with osteoporosis are projected to increase in magnitude in the next decade. This means a crisis of bone fractures along with the forecasted increased societal and economic burden. Fortunately, substantial advances in the diagnosis and treatment of osteoporosis have emerged in the last decade. In a new Therapeutic Advances in Musculoskeletal Disease review of …
Looking down the 10-year pipeline for bone fractures Read More »
Almost 40 per cent of individuals who experience a hip fracture are unable to walk, or will be institutionalised within a year post-fracture. Furthermore, 60 per cent require assistance one year later. Following a fracture, rehabilitation represents an integral component of the treatment pathway, and can improve a patient’s mobility, mortality and quality of life. …
